Search Discussions

Main Content

  • MS_Navigators
    It will take all of us to find solutions to make MS medications, and the process for getting them, affordable, simple, and transparent. The Institute for Clinical and Economic Review (ICER) is currently conducting a review of disease-modifying therapies for relapsing-remitting and primary progressive forms of multiple sclerosis. If you have MS, whether or not you are taking a disease-modifying therapy, and are over 21, lend your voice by taking this survey by September 14th.